Phase 1 Results Are Extraordinary, Says Chairman Of Scientific Advisory Board As Biomedical Company Preps Phase 2 Trial For MS Treatment - Bayer (OTC:BAYRY), Sanofi (NASDAQ:SNY)

Tiziana Life Sciences (NASDAQ: TSLA) has presented data from its clinical trial showing that five of its six patients with an advanced stage of multiple sclerosis (MS) have shown a reduction in microglia activity,

Related Keywords

Gabriele Cerrone ,Howardl Weiner ,Drug Administration ,Tiziana Life ,Positron Emission Tomography ,Expanded Access ,Secondary Progressive Multiple Sclerosis ,Scientific Advisory Board ,Prepares For Phase ,Matteo Vistocco ,